A polygenic risk score (PRS) based on genes associated with endothelial cell function identifies patients at a higher risk of coronary artery disease, according to a new study. The risk score, which ...
Emmecell receives FDA RMAT designation for EO2002, advancing development of its regenerative cell therapy for corneal ...
Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...
Sepsis, a life-threatening systemic inflammatory response triggered by infection, has long challenged clinicians with its persistently high mortality (up to 40-50% in septic shock). At the heart of ...
The FDA granted regenerative medicine advanced therapy designation to EO2002 for the treatment of corneal edema secondary to ...
A study led by researchers at the Institute for Bioengineering of Catalonia (IBEC), in collaboration with the Proteomics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results